| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/04/2010 | US20100056567 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 03/04/2010 | US20100056532 Compounds that modulate intracellular calcium |
| 03/04/2010 | US20100056530 Glucokinase activators |
| 03/04/2010 | US20100056506 Substituted 2-amino-fused heterocyclic compounds |
| 03/04/2010 | US20100056505 Substituted Pyrazalones |
| 03/04/2010 | US20100056498 Substituted monocyclic cgrp receptor antagonists |
| 03/04/2010 | US20100056492 Compounds and uses thereof - 152 |
| 03/04/2010 | US20100055090 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 03/04/2010 | CA2733648A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 03/03/2010 | EP2159224A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines |
| 03/03/2010 | EP2158199A1 Piperidine compounds and uses thereof |
| 03/03/2010 | EP2018375B1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 03/03/2010 | EP1789401B1 Isoxazoline derivatives and their use as herbicides |
| 03/03/2010 | EP1753719B1 Substituted pyrrolidine-2-ones |
| 03/03/2010 | EP1749001B1 3-piperidinylisochroman-5-ols as dopamine agonists |
| 03/03/2010 | EP1730166B1 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections |
| 03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/03/2010 | CN101663299A Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
| 03/03/2010 | CN101663298A Thiazole derivatives as modulators of g protein-coupled receptors |
| 03/03/2010 | CN101659662A Undoped red organic electroluminescent material and preparation method and applications thereof |
| 03/03/2010 | CN101659661A 2-aryl-3-(tetrahydro-2H-pyran-4-yl)-N-aryl-heterocyclic-propionamide compound, medicinal composition thereof and application thereof |
| 03/02/2010 | US7671221 Modulators of ATP-Binding Cassette transporters |
| 03/02/2010 | US7671214 Modification of the indolium ring to permit a reactive group or conjugated substance at the 3 ring position unexpectedly mitigates the problems of quenching, difficulty in preparing, strong tendency to self-associate (stack); fluorescent dyes; biomarking; uniformity; intensity; photostability |
| 03/02/2010 | US7671212 inhibitor for treating a chemokine mediated disease; cancer, angiogenesis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, pain |
| 03/02/2010 | US7671207 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione |
| 03/02/2010 | US7671197 4-Hydroxy-2-methyl-N-ethyl-N'-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide = <0.05% ("ethylamide") after crushing the wet filter cake obtained by filtering a precipitate obtained by the acidification of a solution of crude meloxicam and sodium methylate; boil,cool, dry |
| 03/02/2010 | US7671092 Paclitaxel enhancer compounds |
| 03/02/2010 | US7671077 Kits for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis (ALS) |
| 03/02/2010 | US7671076 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 03/02/2010 | US7671063 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors |
| 03/02/2010 | US7671051 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 03/02/2010 | US7670205 Crotch-possessing corrective garment |
| 03/02/2010 | CA2394615C Substituted 1,3,4-oxadiazoles and a method of reducing tnf-.alpha. levels |
| 02/25/2010 | WO2010022125A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010021934A2 Azaindole inhibitors of iap |
| 02/25/2010 | WO2010021745A2 Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation |
| 02/25/2010 | WO2010021686A1 Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
| 02/25/2010 | WO2010021149A1 Spiro compound capable of inhibiting acid secretion |
| 02/25/2010 | WO2010020556A1 New bradykinin b1 antagonists |
| 02/25/2010 | WO2010020522A1 Insecticidal compounds |
| 02/25/2010 | WO2010020363A1 Substituted 5-aminopyrazoles and use thereof |
| 02/25/2010 | WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048891 Metasubstituted thiazolidinones, their manufacture and use as a drug |
| 02/25/2010 | US20100048890 Conjugated small molecules |
| 02/25/2010 | US20100048641 Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048568 Pyrimidine hydrazide compounds as pgds inhibitors |
| 02/25/2010 | US20100048555 Imidazothiazole derivatives as mark inhibitors |
| 02/25/2010 | US20100048543 Pyrimidine compounds having ties (tek) inhibitory activity |
| 02/25/2010 | US20100047841 Synthesis of desacetoxytubulysin h and analogs thereof |
| 02/25/2010 | CA2771226A1 New bradykinin b1 antagonists |
| 02/25/2010 | CA2734787A1 Substituted 5-aminopyrazoles and use thereof |
| 02/25/2010 | CA2734487A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | CA2730357A1 Azaindole inhibitors of iap |
| 02/24/2010 | EP2157091A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/24/2010 | EP2157090A1 Pyrazinamide compound |
| 02/24/2010 | EP2157085A1 Oxazole, derivatives of tetracyclines |
| 02/24/2010 | EP2157084A1 5-phenyl-3-pyridazinone derivative |
| 02/24/2010 | EP2155740A1 Hetarylanilines as modulators for amyloid beta |
| 02/24/2010 | EP2155739A1 2-cyclopropyl-thiazole derivatives |
| 02/24/2010 | EP2155738A1 Piperidine-amide derivatives |
| 02/24/2010 | EP2155730A2 Aminopyrimidines useful as kinase inhibitors |
| 02/24/2010 | EP2155726A1 Phthalazinone derivatives and their use as medicament to treat cancer |
| 02/24/2010 | EP2155722A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 02/24/2010 | EP2155717A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
| 02/24/2010 | EP2155716A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 02/24/2010 | EP2155687A1 Diacylglycerol acyltransferase inhibitors |
| 02/24/2010 | EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
| 02/24/2010 | EP2155666A1 Azetidine derivatives and their use as prostaglandin e2 antagonists |
| 02/24/2010 | EP2155194A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/24/2010 | EP2001873B1 Active ingredient combinations with insecticidal properties |
| 02/24/2010 | EP1971580B1 Piperazine compounds with a herbicidal action |
| 02/24/2010 | EP1848705B1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 02/24/2010 | EP1742935B1 Polycyclic pyrazines as potassium ion channel modulators |
| 02/24/2010 | EP1682539B1 Process for preparing thiazolidinediones |
| 02/24/2010 | EP1625121B1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/24/2010 | EP1585728B1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | CN101657447A Aminopyridines useful as inhibitors of protein kinases |
| 02/24/2010 | CN101657446A Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors |
| 02/24/2010 | CN100591679C Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
| 02/23/2010 | US7667041 Cinnamide compound |
| 02/23/2010 | US7667037 Processes for preparation of ziprasidone |
| 02/23/2010 | US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666869 Nitrogen-containing 5-membered ring compound |
| 02/23/2010 | US7666863 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 02/23/2010 | CA2462289C Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 02/23/2010 | CA2345146C Cyanophenyl derivative |
| 02/18/2010 | WO2010019930A1 Urea derivatives as inhibitors of map kinases |
| 02/18/2010 | WO2010019606A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | WO2010019547A1 Imine derivatives as cannabinoid receptor ligands |
| 02/18/2010 | WO2010018686A1 Nitrogenated heterocyclic derivative, and agricultural or horticultural bactericidal agent |
| 02/18/2010 | WO2010018328A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |